Medicare Enrolled

Dr. Christopher Rapuano, MD

Ophthalmology · Philadelphia, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
840 WALNUT ST STE 920, Philadelphia, PA 19107
2159283180
In practice since 2005 (21 years)
NPI: 1437157799 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rapuano from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rapuano? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rapuano

Dr. Christopher Rapuano is an ophthalmology specialist in Philadelphia, PA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Rapuano performed 1,236 Medicare services across 903 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rapuano received a total of $75,162 from 38 pharmaceutical and/or device companies across 312 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rapuano is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years in practice ▲ 1,236 Medicare services $75,162 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,236
Medicare services
Bottom 41% in PA for ophthalmology
903
Unique beneficiaries
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~59 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
485 $67 $120
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
315 $100 $175
Ultrasound scan of cornea to determine thickness
An ultrasound procedure used to measure the thickness of the cornea.
149 $8 $25
CT scan of cornea
A computed tomography scan used to create detailed images of the cornea, the clear front part of the eye.
103 $28 $65
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
80 $129 $275
Slit lamp examination of the eye
This procedure uses a specialized microscope to examine the front portion of the eye.
25 $29 $150
Removal of corneal growth
A procedure to remove an abnormal growth from the cornea, the clear front surface of the eye.
22 $588 $1,500
Tear duct plug insertion
A procedure to insert a small plug into the tear duct opening to help retain tears on the eye surface.
20 $145 $380
Eyelash removal with forceps
This procedure involves the manual removal of eyelashes using forceps. It is a mechanical extraction method performed on the eyelid area.
14 $16 $55
Eye photography
Photographic imaging of the interior structures of the eye.
12 $20 $90
New patient office visit, complex (60-74 min) 11 $170 $335
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$75,162
Total received (2018-2024)
Avg $10,737/year across 7 years
Top 3% in PA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
312
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$56,020 (74.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$14,056 (18.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,086 (6.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,046
2023
$2,005
2022
$7,942
2021
$8,049
2020
$4,662
2019
$16,835
2018
$33,623

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Glaukos Corporation
$1,050
BIOTISSUE HOLDINGS INC.
$267
Oyster Point Pharma, Inc.
$131
Dompe US, Inc.
$127
Tarsus Pharmaceuticals, Inc.
$119
Carl Zeiss Meditec, Inc.
$106
SUN PHARMACEUTICAL INDUSTRIES INC.
$98
Bausch & Lomb Americas Inc.
$45
Sight Sciences, Inc.
$44
Harrow Eye, LLC
$39
ANI Pharmaceuticals, Inc.
$20
Top 3 companies account for 70.8% of 2024 payments
All-time payments by company (2018-2024) ›
Shire North American Group Inc
$32,377
Dompe US, Inc.
$8,806
Novartis Pharmaceuticals Corporation
$7,629
Kala Pharmaceuticals, Inc.
$2,900
Bausch & Lomb, a division of Bausch Health US, LLC
$2,488
Avedro Inc.
$2,250
TissueTech, Inc.
$2,109
TearLab Corp
$2,058
Celularity Inc.
$2,000
Sun Pharmaceutical Industries Inc.
$1,924
Sight Sciences, Inc.
$1,919
Glaukos Corporation
$1,801
BioTissue Holdings, Inc.
$1,346
GlaxoSmithKline, LLC.
$975
Eyevance Pharmaceuticals LLC
$971
Allergan, Inc.
$578
GLAUKOS CORPORATION
$500
Oyster Point Pharma, Inc.
$494
BIOTISSUE HOLDINGS INC.
$267
SUN PHARMACEUTICAL INDUSTRIES INC.
$237
Alcon Vision LLC
$183
TISSUETECH, INC.
$166
Bausch & Lomb Americas Inc.
$157
Carl Zeiss Meditec, Inc.
$152
Thea Pharma Inc.
$135
Tarsus Pharmaceuticals, Inc.
$119
NOVARTIS PHARMACEUTICALS CORPORATION
$110
BIOTISSUE HOLDINGS, INC.
$107
Johnson & Johnson Surgical Vision, Inc.
$87
Allergan Inc.
$86
Mallinckrodt Hospital Products Inc.
$63
ABBVIE INC.
$47
Harrow Eye, LLC
$39
ANI Pharmaceuticals, Inc.
$20
Carl Zeiss Meditec AG
$19
Akorn, Inc.
$19
Oasis Medical, Inc.
$12
EyePoint Pharmaceuticals US, Inc.
$12
Top 3 companies account for 64.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ARGOS · BROMSITE · BromSite (bromfenac ophthalmic solution) 0.075% · CAPITAL EQUIPMENT CART · CE-marked KXLA system · CEQUA · COMBIGAN · Cequa · Clareon · DEXYCU · DUREZOL · DURYSTA · EYSUVIS · Flarex · ILUX · INVELTYS · KXL System · LOTEMAX · LOTEMAX SM · MIEBO · NGENUITY · None Specified · OXERVATE · Oasis TEARS PF · Oxervate · PAZEO · PROKERA · PROLENSA · PURIFIED CORTROPHIN GEL · Photrexa · Prokera · RESTASIS · RESTASIS MULTIDOSE · STELLARIS · Simbrinza · Systane · TEARCARE SYSTEM · TYRVAYA · TearCare SmartLid · TearLab Osmolarity System · Tobradex ST · VEVYE · VUITY · VYZULTA · VisuMax · XDEMVY · XELPROS · XIIDRA · ZIRGAN · Zerviate · Zioptan · iStent · iStent inject Trabecular Micro-Bypass Stent System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (74%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in ophthalmology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for ophthalmology in PA.

Looking for an ophthalmology specialist in Philadelphia?
Compare ophthalmologists in the Philadelphia area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
531
Per 100K population
33.6
County median income
$60,698
Nearest hospital
THOMAS JEFFERSON UNIVERSITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rapuano is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 3% of PA peers, with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rapuano experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Rapuano performed 485 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rapuano receive payments from pharmaceutical companies?
Yes. Dr. Rapuano received a total of $75,162 from 38 companies across 312 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rapuano's costs compare to other ophthalmologists in Philadelphia?
Dr. Rapuano's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rapuano) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →